Cargando…

Eyes that Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proportion of the Real-World Patient Population and Reasons for Exclusion

BACKGROUND: To evaluate the proportion of eyes that do not meet the eligibility criteria of clinical trials on neovascular age-related macular degeneration (AMD) and the reasons for exclusion. METHODS: This retrospective, observational study included 512 eyes of 463 patients diagnosed with treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jae Hui, Kim, Jong Woo, Kim, Chul Gu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068537/ https://www.ncbi.nlm.nih.gov/pubmed/33953966 http://dx.doi.org/10.1155/2021/6635467

Ejemplares similares

Eligibility for faricimab in a real-world neovascular age-related macular degeneration population: a cross-sectional study
por: Jern, Iréne, et al.
Publicado: (2022)

Changing Antiretroviral Eligibility Criteria: Impact on the Number and Proportion of Adults Requiring Treatment in Swaziland
por: Bock, Naomi N., et al.
Publicado: (2016)

Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort
por: von Lewinski, Dirk, et al.
Publicado: (2023)

Why do authors persist in submitting trial reports that do not meet the journal eligibility criteria or AllTrials standards?
por: Noyes, Jane
Publicado: (2023)

Consequences of Real-World Surveillance of Fellow Eyes in Neovascular Age-Related Macular Degeneration
por: Onwuka, Oluchukwu, et al.
Publicado: (2023)

The criteria of eligibility to the extracorporeal treatment
por: Zangrillo, A
Publicado: (2012)

Do Lung Cancer Eligibility Criteria Align with Risk among Blacks and Hispanics?
por: Fiscella, Kevin, et al.
Publicado: (2015)

Evaluation of real-world mobility in age-related macular degeneration
por: Sengupta, Sabyasachi, et al.
Publicado: (2015)

Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis
por: Gabrielle, Pierre-Henry, et al.
Publicado: (2021)

Age-related macular degeneration and the aging eye
por: Ehrlich, Rita, et al.
Publicado: (2008)

Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survival
por: Lambaudie, Eric, et al.
Publicado: (2016)

Real-World Data for Planning Eligibility Criteria and Enhancing Recruitment: Recommendations from the Clinical Trials Transformation Initiative
por: Evans, Scott R., et al.
Publicado: (2021)

Machine learning enabled subgroup analysis with real-world data to inform clinical trial eligibility criteria design
por: Xu, Jie, et al.
Publicado: (2023)

Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with Brolucizumab
por: Zubricky, Ryan, et al.
Publicado: (2023)

Proportional Reasoning Deficit in Dyslexia
por: Cappagli, Giulia, et al.
Publicado: (2023)

Erratum in: Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis
Publicado: (2021)

Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150
por: Sho, Takuya, et al.
Publicado: (2022)

Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations
por: Averitt, Amelia J., et al.
Publicado: (2020)

Smooth pursuit eye movements in patients with macular degeneration
por: Shanidze, Natela, et al.
Publicado: (2016)

Nutrients for Prevention of Macular Degeneration and Eye-Related Diseases
por: Khoo, Hock Eng, et al.
Publicado: (2019)

From Non-symbolic to Symbolic Proportions and Back: A Cuisenaire Rod Proportional Reasoning Intervention Enhances Continuous Proportional Reasoning Skills
por: Abreu-Mendoza, Roberto A., et al.
Publicado: (2021)

Epilepsy surgery: eligibility criteria and presurgical evaluation
por: Ryvlin, Philippe, et al.
Publicado: (2008)

Analysis of Eligibility Criteria Complexity in Clinical Trials
por: Ross, Jessica, et al.
Publicado: (2010)

Real‐world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
por: Oh, Jaewon, et al.
Publicado: (2022)

Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan
por: Chang, Yi-Sheng, et al.
Publicado: (2018)

Real‐world treatment outcomes of neovascular Age‐related Macular Degeneration in the Netherlands
por: Verbraak, Frank D., et al.
Publicado: (2020)

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
por: Blazaki, Styliani, et al.
Publicado: (2023)

Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration
por: Yeom, Hoseok, et al.
Publicado: (2023)

Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration
por: Chan, Clement K., et al.
Publicado: (2023)

Phacoemulsification Surgery in Eyes with Neovascular Age-Related Macular Degeneration
por: Grixti, Andre, et al.
Publicado: (2014)

Training eye movements for visual search in individuals with macular degeneration
por: Janssen, Christian P., et al.
Publicado: (2016)

An Assessment of Vitreous Degeneration in Eyes with Vitreomacular Traction and Macular Holes
por: Ghadiali, Quraish, et al.
Publicado: (2017)

Characterization of age-related macular degeneration in Indian donor eyes
por: Soundara Pandi, Sudha Priya, et al.
Publicado: (2021)

Effects of Vitreomacular Traction on Ranibizumab Treatment Response in Eyes with Neovascular Age-related Macular Degeneration
por: Lee, Kang Hoon, et al.
Publicado: (2015)

A review of research on eligibility criteria for clinical trials
por: Su, Qianmin, et al.
Publicado: (2023)

Who is eligible for randomized trials? A comparison between the exclusion criteria defined by the ISCHEMIA trial and 3102 real-world patients with stable coronary artery disease undergoing stent implantation in a single cardiology center
por: Wasilewski, Jarosław, et al.
Publicado: (2015)

Individual Test Point Fluctuations of Macular Sensitivity in Healthy Eyes and Eyes With Age-Related Macular Degeneration Measured With Microperimetry
por: Barboni, Mirella Telles Salgueiro, et al.
Publicado: (2018)

Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act
por: Spivey, Christina A., et al.
Publicado: (2018)

Depression and anxiety in age-related macular degeneration
por: Kim, Eung Suk, et al.
Publicado: (2016)

Estimating the proportion of Medicaid-eligible pregnant women in Louisiana who do not get abortions when Medicaid does not cover abortion
por: Roberts, Sarah C. M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ea6hd1ml7bomehl290mh04is2u